Maynard Um
-
-
-
-
-
-
-
Acumen Pharmaceuticals (ABOS) Reiterated at Overweight by Cantor Fitzgerald
-
-
-
-
-
-
-
Acumen Pharmaceuticals partners with JCR for alzheimer's drug development
-
-
-
-
-
-
-
Acumen Pharmaceuticals, Inc. (ABOS) Misses Q3 EPS by 14c
-
-
-
-
-
-
-
Acumen Pharmaceuticals, Inc. (ABOS) Misses Q2 EPS by 7c
-
-
434,500 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

